Commission Implementing Regulation (EU) 2019/336 of 27 February 2019 amending Regulation (EU) No 1141/2010 and Implementing Regulation (EU) No 686/2012 as regards the rapporteur Member State for the evaluation of 1-methylcyclopropene, famoxadone, mancozeb, methiocarb, methoxyfenozide, pirimicarb, pirimiphos-methyl and thiacloprid (Text with EEA relevance.)

• CELEX: Implementing Regulation (EU) 2019/336
• Articles: 5

Article 1

Implementing Regulation (EU) No 686/2012 is amended in accordance with Annex I to this Regulation.

Article 2

Regulation (EU) No 1141/2010 is amended in accordance with Annex II to this Regulation.

Article 3

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

It shall apply from 30 March 2019.

However, where a decision has been taken to extend the two year period referred to in Article 50(3) of the Treaty on European Union, this Regulation shall apply from the day following that on which legislation in the field of plant protection products ceases to apply to and in the United Kingdom.

Schedules & Appendices

ANNEX I

ANNEX I

Part A of the Annex to Implementing Regulation (EU) No 686/2012 is amended as follows:

(a)

the entry for 1-methyl-cyclopropene is replaced by the following:

Active substance

Rapporteur Member State

Co-rapporteur Member State

‘1-methyl-cyclopropene

NL’

(b)

the entry for Mancozeb is replaced by the following:

Active substance

Rapporteur Member State

Co-rapporteur Member State

‘Mancozeb

EL’

(c)

the entry for Methiocarb is replaced by the following:

Active substance

Rapporteur Member State

Co-rapporteur Member State

‘Methiocarb

DE’

(d)

the entry for Methoxyfenozide is replaced by the following:

Active substance

Rapporteur Member State

Co-rapporteur Member State

‘Methoxyfenozide

SK’

(e)

the entry for Pirimicarb is replaced by the following:

Active substance

Rapporteur Member State

Co-rapporteur Member State

‘Pirimicarb

SE’

(f)

the entry for Pirimiphos-methyl is replaced by the following:

Active substance

Rapporteur Member State

Co-rapporteur Member State

‘Pirimiphos-methyl

FR’

(g)

the entry for Thiacloprid is replaced by the following:

Active substance

Rapporteur Member State

Co-rapporteur Member State

‘Thiacloprid

DE’

ANNEX II

ANNEX II

In Annex I to Regulation (EU) No 1141/2010, the entry for Famoxadone is replaced by the following:

Column A

Column B

Column C

Column D

‘Famoxadone

2012

FI

31 August 2012’